These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32914480)

  • 1. Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1/TAZ-PPARγ/PGC-1α signaling pathway.
    Luo C; Sun H; Peng J; Gao C; Bao L; Ji R; Zhang C; Zhu W; Jin Y
    Phytother Res; 2021 Feb; 35(2):1010-1022. PubMed ID: 32914480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosmarinic acid ameliorated cardiac dysfunction and mitochondrial injury in diabetic cardiomyopathy mice via activation of the SIRT1/PGC-1α pathway.
    Diao J; Zhao H; You P; You H; Wu H; Shou X; Cheng G
    Biochem Biophys Res Commun; 2021 Mar; 546():29-34. PubMed ID: 33561745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lemon Balm and Its Constituent, Rosmarinic Acid, Alleviate Liver Damage in an Animal Model of Nonalcoholic Steatohepatitis.
    Kim M; Yoo G; Randy A; Son YJ; Hong CR; Kim SM; Nho CW
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32331258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway.
    Zhang X; Ji R; Sun H; Peng J; Ma X; Wang C; Fu Y; Bao L; Jin Y
    Free Radic Res; 2018 Feb; 52(2):198-211. PubMed ID: 29400110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosmarinic acid exerts an antagonistic effect on vascular calcification by regulating the Nrf2 signalling pathway.
    Ji R; Sun H; Peng J; Ma X; Bao L; Fu Y; Zhang X; Luo C; Gao C; Jin Y; Sun S
    Free Radic Res; 2019 Feb; 53(2):187-197. PubMed ID: 30864863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
    Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
    Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosmarinic acid alleviates di-2-ethylhexyl phthalate (DEHP) -induced thyroid dysfunction via multiple inflammasomes activation.
    Wu H; Ma K; Na X
    J Toxicol Sci; 2020; 45(7):373-390. PubMed ID: 32612006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
    Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
    Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model.
    Xu Z; Lin S; Tong Z; Chen S; Cao Y; Li Q; Jiang Y; Cai W; Tong Y; Zahra BS; Wang P
    J Ethnopharmacol; 2022 Mar; 285():114873. PubMed ID: 34848360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
    Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
    Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of rosmarinic acid against oxidative stress biomarkers in liver and kidney of strepotozotocin-induced diabetic rats.
    Mushtaq N; Schmatz R; Ahmed M; Pereira LB; da Costa P; Reichert KP; Dalenogare D; Pelinson LP; Vieira JM; Stefanello N; de Oliveira LS; Mulinacci N; Bellumori M; Morsch VM; Schetinger MR
    J Physiol Biochem; 2015 Dec; 71(4):743-51. PubMed ID: 26452500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T; Zhu J; Zhu L; Cheng M
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway.
    Chi Y; Gong Z; Xin H; Wang Z; Liu Z
    J Transl Med; 2020 Mar; 18(1):126. PubMed ID: 32169080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Rab18 on liver injury and lipid accumulation by regulating perilipin 2 and peroxisome proliferator-activated receptor gamma in non-alcoholic fatty liver disease.
    Zhang L; Xu L; Rong A; Cui Y; Wang L; Li L; Han X; Xiao X; Wu H
    J Gastroenterol Hepatol; 2024 Jul; ():. PubMed ID: 39030773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
    Wang J; Jiang W
    Med Sci Monit; 2020 Feb; 26():e919220. PubMed ID: 32026851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.